MS
Therapeutic Areas
Polymedco Pipeline
| Drug | Indication | Phase |
|---|---|---|
| PATHFAST hs-cTnI-II | Myocardial Infarction / Acute Coronary Syndrome | Approved |
| CRC Screening Program | Colorectal Cancer Screening | Commercial |
| Cardiac POC Testing Program | Cardiac Disease Management | Commercial |
Leadership Team at Polymedco
DW
Doug White
Chief Executive Officer
CM
Chris Mathews
Interim Chief Executive Officer | Chief Financial and Operations Officer
JS
Jason Sak
Chief Commercial Officer
TW
Todd W. Kelley
Vice President of Medical Affairs
TP
Tara Pucci
Vice President of Operations